What is the global market size of Peptide Therapeutics Market?

Global Peptide Therapeutics Market size was valued at USD 40.69 billion in 2021 and is poised to grow from USD 43.11 billion in 2022 to USD 68.4 billion by 2030, growing at a CAGR of 5.94% in the forecast period (2023-2030).

Global Peptide Therapeutics Market Size, Share, Growth Analysis, By Application(Cancer, Metabolic), By Type of Manufacturers(In-house, Outsourced), By Type(Generic, Innovative), By Route of Administration(Parenteral, Oral), By Synthesis Technology(Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS)) - Industry Forecast 2024-2031

Report ID: SQMIG35H2072 | Region: Global | Published Date: February, 2024
Pages: 213 | Tables: 152 | Figures: 78

Global Peptide Therapeutics Market Insights

Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).

The acceptability of peptide therapies will be impacted by the rise in cancer cases as well as metabolic illnesses like osteoporosis, obesity, and diabetes. Due to the sheer increase in the number of pediatric kids affected and the frequency of the target diseases in low-income countries, there is a tremendous demand for efficient and affordable treatments.

Advanced peptides are now being developed and modified for the treatment COVID-19. Researchers from all over the world are hunting for substances that either alleviate the circumstances brought on by infection or stop the mechanisms involved in severe acute respiratory infection and replication. On February 21, 2020, the Food and Drug Administration revised its definition of a biologic to include synthetic peptides with 40 amino acids or fewer and chemically produced polypeptides larger than 40 amino acids but smaller than 100 amino acids. Due to the fact that peptide medications are now being considered as a possible COVID-19 treatment, COVID-19 may have a significant impact on the market.

US Peptide Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Peptide Therapeutics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Technology innovations and the development of new products are important techniques used by companies to acquire market share. Additionally, it is predicted that growing alliances for conducting new drug trials will enhance rivalry in the industry. For instance, Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced a new agreement in May 2022, according to which Pfizer will procure Biohaven, the producer of NURTEC ODT, an advanced dual-acting migraine therapy approved for both acute treatments and episodic migraine prevention in adults. The key market players involved in the manufacture of automotive gears includes; 'Amgen, Inc.', 'AstraZeneca plc', 'Bachem Holding AG', 'Bristol-Myers Squibb Company', 'Eli Lilly and Company', 'Ipsen S.A.', 'Merck & Co., Inc.', 'Novartis AG', 'Novo Nordisk A/S', 'Pfizer Inc.', 'Sanofi S.A.', 'Takeda Pharmaceutical Company Limited', 'Teva Pharmaceutical Industries Ltd.', 'Lonza Group AG', 'Ferring Pharmaceuticals, Inc.', 'PolyPeptide Group', 'Protagonist Therapeutics, Inc.', 'Ipsen Biopharmaceuticals, Inc.', 'Polytherapeutics Inc.', 'Zealand Pharma A/S'

Due to their high specificity, discernment, tiny sizes, simplicity of modification, and high biocompatibility, peptide therapies are used as targets in the administration of anti-cancer medications. The segment is expanding due to elements like the rising cancer burden, new launches, and research and development.

The majority of peptide medications are currently given through the parenteral route, and about 75% are given as injectables. However, in accordance with the corresponding technological advancements, alternate administration modalities, including as oral, intranasal, and transdermal delivery routes, are gaining more and more popularity.

The peptide therapeutics market was dominated by North America in 2021. The rise of the regional market is primarily attributed to the expansion of the biotechnology industry, increasing demand for cancer and other disease diagnostics, and expanding consumer awareness of peptide treatment products. Additionally, it is projected that increased government spending on R&D will support peptide treatments' continued supremacy over the forecast period. The region's well-established biotech and pharmaceutical sectors are a major contributor to the expansion. According to the American Cancer Society, 1.9 million more cancer cases are expected in the United States in 2022. Cancer is the second most common cause of death in the country, behind heart disease.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Peptide Therapeutics Market Insights

Global Peptide Therapeutics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Peptide Therapeutics Market?

Who are the key vendors in the Global Peptide Therapeutics Market?

What is the key driver of Global Peptide Therapeutics Market?

What is the key market trend for Global Peptide Therapeutics Market?

Which region accounted for the largest share in Global Peptide Therapeutics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300